Allergan USA, Inc. v. Prollenium US Inc.
1:20-cv-00104
Overview
Parties
Defendant
Prollenium Medical Technologies Inc. NPE (Patent Assertion Entity)
Represented By
4 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Prollenium US Inc. Operating Company
Represented By
4 Attorneys ListedAshby & Geddes
Ashby & Geddes, 500 Delaware Avenue, 8th Floor
Plaintiff
Allergan Industrie SAS Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Allergan USA, Inc. Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 9 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | US 10,391,202 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 11,173,232 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 2022031387 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,595,608 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,793,408 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,627,808 P | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 8,450,475 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 9,358,322 B2 | US Continuation / Sibling | View Official Patent → |
| πΊπΈ United States | US 10,328,180 B2 | US Continuation / Sibling | View Official Patent → |
Prollenium US Inc. et al. v. Allergan Industrie, SAS et al.
Prollenium US Inc. et al. v. Allergan Industrie, SAS et al.
Prollenium US, Inc. v. Allergan Industrie, SAS
Prollenium US, Inc. v. Allergan Industrie, SAS
TEOXANE S.A. v. Allergan, plc et al.
Galderma S.A. et al. v. Allergan Industrie, SAS et al.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US10391202
Hyaluronic acid-based gels including lidocaine
|
Filed: 2018-11-09
Issued: 2019-08-27
|
Active (12.0 yrs remaining)
Expires: 2038-11-09
|
|
|
US10485896
Hyaluronic acid-based gels including lidocaine
|
Filed: 2018-11-09
Issued: 2019-11-26
|
Active (12.0 yrs remaining)
Expires: 2038-11-09
|
Patent Enforceability & Injunction Risk Assessment
Active Threat β Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term β No obviousness-type double patenting truncation noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
27
Dispositive
18
Granted
2
Denied
0
Pending / Review
14
Motions by Category
Key Dispositive Motions & Rulings